Home › Agent Hub › Agent Tools › Part D coverage by drug › Anoro
Agent Tools
Anoro is a brand of umeclidinium / vilanterol. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,063 of 5,492 Medicare Part D and Medicare Advantage drug plans (74%) list Anoro on their formulary, across 242 of 286 formularies. The most common placement is tier 3 (3,672 plans, 90.4% of those covering it). 0 of the covering plans require prior authorization (0%), 0 step therapy and 4,043 a quantity limit.
396 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $42, 68 of them $0; 3,667 charge coinsurance instead — median 22% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 4,330 of 5,496 plans covered it (78.8%); 2027: 4,063 of 5,492 (74%).
Of 4,367 plans offered in both years, 8 added it to the formulary and 225 dropped it.
Among plans covering it both years, 48 moved it to a higher tier and 233 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 116 |
| Tier 2 | 275 |
| Tier 3 | 3,672 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 220 of 323 | 68.1% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,321 of 3,200 | 72.5% | 0% |
| Special needs plans (SNP) | 1,522 of 1,969 | 77.3% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 830 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 0 |
| Aetna Medicare | 631 of 631 | Tier 3 | 0 |
| Wellcare | 268 of 268 | Tier 2 | 0 |
| HealthSpring | 226 of 226 | Tier 3 | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 3 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 3 | 0 |
| Anthem Blue Cross and Blue Shield | 0 of 74 | No tier listed | 0 |
| Wellpoint | 0 of 63 | No tier listed | 0 |
| Priority Health Medicare | 40 of 40 | Tier 3 | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 36 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 35 of 35 | Tier 3 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 0 of 26 | No tier listed | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 3 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 95 of 114 | 83.3% |
| Alaska | 6 of 9 | 66.7% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 111 of 147 | 75.5% |
| Arkansas | 62 of 85 | 72.9% |
| California | 279 of 397 | 70.3% |
| Colorado | 73 of 106 | 68.9% |
| Connecticut | 41 of 54 | 75.9% |
| Delaware | 34 of 43 | 79.1% |
| District of Columbia | 8 of 12 | 66.7% |
| Florida | 376 of 545 | 69% |
| Georgia | 102 of 149 | 68.5% |
| Guam | 1 of 1 | 100% |
| Hawaii | 36 of 50 | 72% |
| Idaho | 26 of 45 | 57.8% |
| Illinois | 95 of 132 | 72% |
| Indiana | 82 of 138 | 59.4% |
| Iowa | 53 of 64 | 82.8% |
| Kansas | 63 of 84 | 75% |
| Kentucky | 63 of 121 | 52.1% |
| Louisiana | 75 of 125 | 60% |
| Maine | 32 of 52 | 61.5% |
| Maryland | 32 of 49 | 65.3% |
| Massachusetts | 82 of 89 | 92.1% |
| Michigan | 163 of 182 | 89.6% |
| Minnesota | 41 of 63 | 65.1% |
| Mississippi | 80 of 104 | 76.9% |
| Missouri | 123 of 170 | 72.4% |
| Montana | 7 of 27 | 25.9% |
| Nebraska | 40 of 51 | 78.4% |
| Nevada | 70 of 100 | 70% |
| New Hampshire | 16 of 25 | 64% |
| New Jersey | 58 of 73 | 79.5% |
| New Mexico | 54 of 68 | 79.4% |
| New York | 192 of 215 | 89.3% |
| North Carolina | 143 of 176 | 81.3% |
| North Dakota | 16 of 26 | 61.5% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 117 of 171 | 68.4% |
| Oklahoma | 58 of 81 | 71.6% |
| Oregon | 75 of 92 | 81.5% |
| Pennsylvania | 292 of 323 | 90.4% |
| Puerto Rico | 20 of 64 | 31.3% |
| Rhode Island | 26 of 29 | 89.7% |
| South Carolina | 66 of 89 | 74.2% |
| South Dakota | 18 of 30 | 60% |
| Tennessee | 126 of 156 | 80.8% |
| Texas | 305 of 407 | 74.9% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 38 of 53 | 71.7% |
| Vermont | 7 of 14 | 50% |
| Virginia | 79 of 144 | 54.9% |
| Washington | 74 of 114 | 64.9% |
| West Virginia | 44 of 69 | 63.8% |
| Wisconsin | 67 of 96 | 69.8% |
| Wyoming | 7 of 13 | 53.8% |
Medicare Part D paid for 1,819,418 30-day fills of Anoro in 2024 for about 291,120 enrollees, at an average total cost of $449.47 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Anoro and the rest of a client's list on every plan in their county.
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.